Reports preliminary adjusted EBITDA of approximately $588M. Sees FY25 revenue of $11.5B-$12B, consensus $12.39B. Sees FY25 adjusted EBITDA of $540M-$555M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health price target raised to $22 from $20 at Mizuho
- BrightSpring Health price target raised to $20 from $19 at Morgan Stanley
- BrightSpring Health initiated with an Outperform at CJS Securities
- BrightSpring Health Services Achieves Major Loan Refinancing
- BrightSpring Health price target raised to $21 from $19 at BofA